Status:
COMPLETED
Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery
Lead Sponsor:
Ito Hospital
Conditions:
Thyroid Disease
Parathyroid Disease
Eligibility:
All Genders
10-90 years
Phase:
NA
Brief Summary
The effectiveness of antimicrobial prophylaxis (AMP) for prevention of surgical site infection (SSI) following thyroid and parathyroid surgery remains uncertain. Present prospective randomized control...
Detailed Description
Between November 2010 and April 2012, 2164 consecutive patients who agreed to attend the randomized control study were enrolled. All the participants received surgery for thyroid and parathyroid disea...
Eligibility Criteria
Inclusion
- Between November 2010 and April 2012, 2164 consecutive patients who agreed to attend the randomized control study were enrolled. All the participants received surgery for thyroid and parathyroid disease at Ito Hospital.
Exclusion
- Patients who did not agree to attend the randomized control study.
- Patients who received the operation including mediastinum with sternotomy.
- Patients who received the operation including additional resection of trachea, esophagus and larynx.
- Patients who received the re-operation for post-operative bleedings.
- Patients who had known allergy to cephem or penicillin.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
2164 Patients enrolled
Trial Details
Trial ID
NCT01805856
Start Date
November 1 2010
End Date
May 1 2012
Last Update
March 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ito Hospital
Tokyo, Japan, 150-8308